Orientador: Vagner de CastroTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências MédicasResumo:Abstract:DoutoradoClinica MedicaDoutora em Ciência
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Pengurusan pesakit yang membentuk kerintangan imun terhadap platelet adalah mencabar. Salah satu kae...
Platelet transfusion refractoriness results in adverse outcomes and increased health care costs. Man...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
Background: The selection of compatible human leukocyte antigen platelets has been associated with i...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
Background and Objectives: Transfusion support for immune-mediated platelet refractoriness (PR) is c...
BACKGROUND: For HLA-alloimmunized patients, platelet (PLT) concentrations are provided either at mat...
Entre outubro de 1997 e julho de 1999 pesquisou-se a refratariedade plaquetária em 15 pacientes na f...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (8...
International audienceThe platelet refractoriness is a complication of transfusion treatments potent...
OBJECTIVE: The objective of this study was to evaluate the frequencies of human platelet antigens in...
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring inte...
Entre outubro de 1997 e julho de 1999 pesquisou-se a refratariedade plaquetária em 15 pacientes na f...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Pengurusan pesakit yang membentuk kerintangan imun terhadap platelet adalah mencabar. Salah satu kae...
Platelet transfusion refractoriness results in adverse outcomes and increased health care costs. Man...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
Background: The selection of compatible human leukocyte antigen platelets has been associated with i...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
Background and Objectives: Transfusion support for immune-mediated platelet refractoriness (PR) is c...
BACKGROUND: For HLA-alloimmunized patients, platelet (PLT) concentrations are provided either at mat...
Entre outubro de 1997 e julho de 1999 pesquisou-se a refratariedade plaquetária em 15 pacientes na f...
Platelet transfusion refractoriness (PTR) is the major complication of long-term platelet supportive...
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (8...
International audienceThe platelet refractoriness is a complication of transfusion treatments potent...
OBJECTIVE: The objective of this study was to evaluate the frequencies of human platelet antigens in...
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring inte...
Entre outubro de 1997 e julho de 1999 pesquisou-se a refratariedade plaquetária em 15 pacientes na f...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
Pengurusan pesakit yang membentuk kerintangan imun terhadap platelet adalah mencabar. Salah satu kae...
Platelet transfusion refractoriness results in adverse outcomes and increased health care costs. Man...